Rosuvastatin best cost option for dyslipidaemia in Mexico

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.602, 2010-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Allopurinol still best cost option in chronic gout

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia

By Davidson Michael H

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 1, 2002-01 ,pp. : 125-141

Informa Healthcare

Access to resources Recommend Favorite

Which strategy best cost option for vaginal agenesis?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 615, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Dyslipidaemia in diabetes: combination statin treatment an option

Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Rosuvastatin: cost analyses from JUPITER

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite